glp 1 gip mechanism of action Understand GLP-1/GIP Dual Agonist Tirzepatide and Its Effect on Current Weight Loss Therapy Targeting GLP-1, GIP & GCG
Description
GLP-1 agonists are a class of Type 2 diabetes drugs that improves blood sugar control but may also lead to weight loss
doi: 10.7150/thno.15993
With brand-name versions like Wegovy, Ozempic, and Mounjaro, often priced at more than $1,000 per month and limited insurance coverage, compounded versions of these agents have filled a temporary but vital gap
where industry pioneers explore cutting-edge strategies across oligos, peptides, mRNA, and genome editing to transform therapeutics from discovery to market reality
